NDC11 00121082004
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00121-0820-04 | 00121-0820 |
| 00121-0820-4 | 00121-0820 |
| 00121-820-04 | 00121-820 |
| 0121-0820-04 | 0121-0820 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| THEOPHYLLINE | THEOPHYLLINE | PAI Holdings, LLC dba PAI Pharma | 32b9780f-c46f-4e0f-9641-2cab60600e6e | 2024-11-19 | Warnings, Adverse reactions | 0121-0820-04 0121-0820 00121082004 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.